Loading...

RCOphth Annual Congress 2026

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

296 posters, 7 videos, 13 audios, 14 topics, 10 sessions, 1,019 authors, 260 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

RCOphth Annual Congress 2026

18 - 21 May, 2026 | Manchester Central, Manchester

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

P206

Two-Year�Effectiveness, Durability�and Safety of�Faricimab�in Eyes�With�Neovascular�Age Related�Macular�Degeneration: Results�From�the UK FARWIDE-nAMD�Study

Preview of Two-Year�Effectiveness, Durability�and Safety of�Faricimab�in Eyes�With�Neovascular�Age Related�Macular�Degeneration: Results�From�the UK FARWIDE-nAMD�Study

View Poster Contact Presenter

Poster Presenter

Samantha De Silva

Authors

Samantha de Silva, Deepali Varma, Gabriella De Salvo, James Talks, Praveen Patel, Richard Gale, Gloria Chi, Abigail Darnell, Melanie Dodds, Parul Dayal

Affiliations

NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital, London, UK, Genentech, Inc., South San Francisco, CA, USA, Roche Products Ltd., Welwyn Garden City, UK, Oxford University Hospitals NHS Foundation Trust, Oxford, UK, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, UK,

Part of Topic

Medical retina

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

University Hospital Southampton NHS Foundation Trust, Southampton, UK, and University of Southampton, Southampton, UK,

Hull York Medical School, York and Scarborough Teaching Hospitals NHS Foundation Trust, Hull, UK,

Medisoft Ltd., Leeds, UK,

Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK

Other ePosters in

Topic

P12912-Month Real-World Clinical and Anatomical Outcomes�With�Faricimab in P...

P13012-month real-world outcomes of switching to aflibercept 8 mg in subopti...

P1312-year real-world outcomes�from the use of Faricimab in neovascular�age-...

P132A Comparative Audit of Faricimab (Vabysmo) versus Aflibercept (Eylea) in...

P133A Novel Ophthalmic Stent Concept to Improve Choroidal Perfusion in Geogr...

ePosters in

Topics

Audit and clinical governance(27)Case reports(34)Cataract and refractive surgery(16)Cornea and ocular surface(13)Emergency ophthalmology(9)Glaucoma(27)Medical retina(79)Miscellaneous(26)Neuro ophthalmology(8)Orbit and oculoplastics(6)